首页 | 本学科首页   官方微博 | 高级检索  
     检索      

人硫氧还蛋白对脑缺血作用的CT灌注与SOD相关性的实验研究
引用本文:范义,滕妍,张启周,胡卫东,娄明武.人硫氧还蛋白对脑缺血作用的CT灌注与SOD相关性的实验研究[J].北华大学学报(自然科学版),2005,6(4):306-310.
作者姓名:范义  滕妍  张启周  胡卫东  娄明武
作者单位:深圳市龙岗中心医院,广东,深圳,518116;深圳市妇幼保健院,广东,深圳,518116
摘    要:目的研究人硫氧还蛋白(hTRX)对局灶性兔脑缺血/再灌注损伤后脑组织的保护作用,并探讨其清除氧自由基的生物学活性.方法采用线栓法制成一侧兔脑缺血/再灌注模型(栓塞6 h,再灌注18 h),将25只雄性新西兰白兔随机分成假手术组(Sham组,5只)、缺血/再灌注组(I/R组,10只)和缺血/再灌注 hTRX治疗组(I/R hTRX组,10只),I/R hTRX组给予hTRX(0.75 mg/kg体质量),Sham组、I/R组以等容积的生理盐水取代hTRX;分别于梗死后6 h及再灌注后18 h做CT灌注图像,观察脑梗死面积,计算出其所占同侧大脑半球面积的百分比(HLA%);检测脑组织匀浆中SOD,MDA含量.结果脑缺血/再灌注后,脑梗死范围显著,脑组织匀浆中SOD明显下降,MDA明显升高(与假手术组比较,P<0.01);而应用hTRX能显著减小脑梗死面积,降低MDA及升高SOD含量(与B组比较,P<0.01).结论重组hTRX对脑缺血/再灌注损伤有显著的治疗作用.

关 键 词:人硫氧还蛋白  氧自由基  CT灌注成像  脑缺血/再灌注
文章编号:1009-4822(2005)04-0306-05
收稿时间:2005-03-15
修稿时间:2005年3月15日

Experimental Study of Human Thioredoxin(hTRX) on Injury of Cerebral Ischemia by Perfusion CT and SOD
FAN Yi,Teng Yan,ZHANG Qi-zhou,HU Wei-dong,LOU Ming-wu.Experimental Study of Human Thioredoxin(hTRX) on Injury of Cerebral Ischemia by Perfusion CT and SOD[J].Journal of Beihua University(Natural Science),2005,6(4):306-310.
Authors:FAN Yi  Teng Yan  ZHANG Qi-zhou  HU Wei-dong  LOU Ming-wu
Abstract:ObjectiveTo investigate the function on decreasing cerebral ischemia/reperfusion injury with hTRX, and to discuss its biology capability.MethodsUnilateral cerebral ischemia/reperfusion models of rabbit were obtained by the intraluminal filament technique(ischemia for 6 hours followed by reperfusion for 18 hours). 25 rabbits were randomly divided into sham operation group(Group Sham,n=5), ischemia/reperfusion group(Group I/R,n=10), and the recombinant hTRX protein treatment group(Group I/R+hTRX,n=10).The recombinant hTRX protein was administered intravenously to Group I/R+hTRX((0.75 mg/kg) body weight), and the same volume of Sodium Chloride instead of the hTRX protein was given intravenously to Group Sham and Group I/R. Perfusion CT scans were made respectively after ischmia 6 hours and reperfusion 18 hours, and the cerebral ischmia areas were observed ,then the percents(HLA%) of ischmia areas account for the same cerebral areas were calculated. Surperoxide dismutase(SOD), maloudialdehyde(MDA) were measured.ResultsAfter cerebral ischemia/reperfusion, the ranges of cerebral ischemia were obviously, and SOD activity in the brain tissues decreased significantly and MDA content increased remarkably(compared with sham groups, P<(0.01)). The ischemia areas greatly reduced by using hTRX, MDA content decreased, SOD activity increased greatly(compared with I/R group,P<(0.01)).ConclusionThe recombinant hTRX protein has a great role to treat cerebral ischemia/reperfusion injury.
Keywords:Human Thioredoxin(hTRX)  Oxygen free radicals  Perfusion CT  Cerebral ischemia/reperfusion
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号